Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis: A case report

被引：1
|
作者：
Mahmoudi, Farhad [1 ]
Emami, Sayed Ali [1 ]
Masaeli, Farid [1 ]
Rayatpisheh, Najmeh [2 ]
机构：
[1] Isfahan Univ Med Sci, Med Sch, Esfahan, Iran
[2] Shahrekord Univ Med Sci, Sch Med, Shahrekord, Iran
来源：
CLINICAL CASE REPORTS | 2023年 / 11卷 / 11期
关键词：
alemtuzumab; DMT; epistaxis; immune thromboctopenic purpura; ITP; MS; multiple sclerosis; RRMS;
D O I：
10.1002/ccr3.8143
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Here, we present a case of relapsing-remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care. Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis.image
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Efficacy of alemtuzumab in relapsing-remitting multiple sclerosis is independent of baseline status
    Coles, A. J.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 : 55 - 55
  • [22] Alopecia totalis following alemtuzumab treatment in relapsing-remitting multiple sclerosis
    Zimmermann, J.
    Buhl, T.
    Mueller, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 382 - 382
  • [23] The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
    Alroughani, Raed
    Van Wijmeersch, Bart
    Al Khaboori, Jabber
    Alsharoqi, Isa Ahmed
    Ahmed, Samar F.
    Hassan, Ali
    Inshasi, Jihad
    Krieger, Derk W.
    Shakra, Mustafa
    Shatila, Ahmed Osman
    Szolics, Miklos
    Khallaf, Mohamed
    Ezzat, Aly
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [24] Effect of alemtuzumab on quality of life in patients with relapsing-remitting multiple sclerosis
    Bass, Ann
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (11): : 1396 - 1396
  • [25] Alemtuzumab Improves Contrast Sensitivity in Relapsing-Remitting Multiple Sclerosis Patients
    Balcer, Laura
    Galetta, Steven
    Maguire, Maureen
    Palmer, Jeffrey
    Margolin, David
    Rizzo, Marco
    [J]. NEUROLOGY, 2011, 76 (09) : A446 - A446
  • [26] Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
    Penkert, Horst
    Delbridge, Claire
    Wantia, Nina
    Wiestler, Benedikt
    Korn, Thomas
    [J]. JAMA NEUROLOGY, 2016, 73 (06) : 757 - 759
  • [27] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [28] NatalizumabRebound effect in the form of relapsing-remitting multiple sclerosis: case report
    [J]. Reactions Weekly, 2022, 1931 (1) : 463 - 463
  • [29] Rehabilitation Challenges in a Patient with Relapsing-Remitting Multiple Sclerosis
    Aleksanyan, M.
    Choudhury, M.
    Oo, T. N.
    Shil, A. B.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S272 - S272
  • [30] Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
    María Rosario Blasco
    Antonio Ramos
    Celia García Malo
    Antonio García-Merino
    [J]. Journal of Neurology, 2017, 264 : 168 - 169
12345